Design, synthesis, and antitumor mechanism investigation of iridium(III)/ruthenium(II)-vadimezan conjugates towards 4T1 cells.

vadimezan (ASA404) - Antisoma

http://www.ncbi.nlm.nih.gov/pubmed/41581360

Chun-Rong Jiang; Hou Zhu; Meng-Ting Xu; Rong-Tao Li; Rui-Rong Ye; Yong-Sheng Yang; Zheng Zhang

Jan 26, 2026